Biography:

1.Education:

1994-1999, Bachelor of Medicine, China Medical University

1999-2002, Master of Oncology, China Medical University

2008-2012, PhD of Integrated Chinese and Western, Zhejiang University of traditional Chinese medicine

2.Work experience:

August 2002-December 2005, Resident, Department of Radiation Oncology, Zhejiang Cancer Hospital

December 2005-December 2010, Attending doctor, Department of Radiation Oncology, Zhejiang Cancer Hospital

January 2011-December 2019, Associate chief Physician, Department of Radiation Oncology, Zhejiang Cancer Hospital

December 2019-March 2021, Chief physician, Department of Radiation Oncology, Zhejiang Cancer Hospital

April 2021-Present, Chief physician, Department of Radiation Oncology, Women's Hospital, School of Medicine, Zhejiang University

3.Main Professional affiliations:

Member of the Brachytherapy Branch of the Credit Committee for Radiation Oncology, Chinese Medical Association

Member of Gynecological Oncology Branch Association, Medical Association of Zhejiang Province 

Deputy director of the Gynecological Oncology Group of the Chinese Research Hospital Association and the MDT Professional Committee for Oncology

Member of the Oncology of Integrated Chinese and Western medicine Branch Association of Zhejiang Province

Member of the Mathematical Medicine Platform of the Zhejiang mathematical Medical Association

Member of the Nutritional Support Therapy Group of the Oncology Branch, Medical Association of Zhejiang Province 

Standing Committee of Radiation Oncology Special Committee of Geriatric Health Association

Research areas:

1.For clinical, Has been engaged in radiation oncology for more than 20 years; At present, Mainly engaged in the combined treatment of gynecological tumors such as cervical cancer, endometrial cancer, vulvar cancer and vaginal cancer; And is good at individualized three-dimensional brachytherapy of cervical cancer; Accumulated rich clinical experience in the combined treatment of recurrent and metastatic cervical cancer, endometrial cancer and vulvar cancer. Participated in 2 multicenter clinical studies as a sub-PI in China.

2.For academic, Mainly engaged in the research of mechanism in radiation enteritis injury and sensitivity of radiotherapy and chemotherapy of gynecological tumors.

Research projects:

Protective effect of fecal flora transplantation on radiation enteritis in mice and screening of bacteria related to radiation enteritis in clinical cervical cancer patients. Exploration project of Natural Science Foundation of Zhejiang Province, Y20H220001

Publications:

1. Tang Q, Hu QY, Piao YF, Hua YH. Correlation between pretreatment serum LDL-cholesterol levels and prognosis in nasopharyngeal carcinoma patients. Onco Targets Ther. 2016 May 2;9:2585-91. (First author)

2. Sun HY, Tang Q, Chen JH, Lv XJ, Tu YQ, Yan DD. Cisplatin concurrent chemoradiotherapy vs adjuvant radiation in stage IB/IIA cervical cancer with intermediate risk factors, treated with radical surgery: a retrospective study. Onco Targets Ther. 2018 Mar 6;11:1149-1155. (Corresponding author)

3. Yan DD, Tang Q, Chen JH, Tu YQ, Lv XJ. Prognostic value of the 2018 FIGO staging system for cervical cancer patients with surgical risk factors. Cancer Manag Res. 2019 Jun 13;11:5473-5480. (Corresponding author)

4. Yan DD, Tang Q, Tu YQ, Chen JH, Lv XJ. A comprehensive analysis of the factors of positive pelvic lymph nodes on survival of cervical cancer patients with 2018 FIGO stage IIIC1p. Cancer Manag Res. 2019 May 7;11:4223-4230. (Corresponding author)

5. Lv XJ, Cheng XL, Tu YQ, Yan DD, Tang Q. Association between the location of transposed ovary and ovarian dose in patients with cervical cancer treated with postoperative pelvic radiotherapy. Radiat Oncol. 2019 Dec 16;14(1):230. (Corresponding author)

6. Wang J, Chen Y, Xie H, Luo L, Tang Q. Evaluation of auto-segmentation for EBRT planning structures using deep learning-based workflow on cervical cancer. Sci Rep. 2022 Aug 11;12(1):13650. (Corresponding author)